Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome

BJU International

Volumn 111, Issue 4, 2013, Pages 638-646

  Shie, Jia Heng ^a   Liu, Hsin Tzu ^a   Wang, Yu Syuan ^a   Kuo, Hann Chorng ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

Author keywords

botulinum toxin A; inflammation; interstitial cystitis; urothelial dysfunction

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; BOTULINUM TOXIN A; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TRYPTASE;

ADULT; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BLADDER BIOPSY; BLADDER CAPACITY; CELL ACTIVITY; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFICACY; ENZYME INACTIVATION; FEMALE; GLOBAL RESPONSE SCORE; GLOMERULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL CYSTITIS; MAST CELL; NICK END LABELING; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; URODYNAMICS; VISUAL ANALOG SCALE; WESTERN BLOTTING;

ADMINISTRATION, INTRAVESICAL; BIOPSY, NEEDLE; BLOTTING, WESTERN; BOTULINUM TOXINS, TYPE A; COHORT STUDIES; CYSTITIS, INTERSTITIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MIDDLE AGED; PAIN MEASUREMENT; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; URODYNAMICS;

EID: 84875853359     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11466.x     Document Type: Article

References (26)

1. Chancellor MB, Yoshimura N,. Treatment of interstitial cystitis. Urology 2004; 63 (3 Suppl 1): 85-92
2. Saini R, Gonzalez RR, Te AE,. Chronic pelvic pain syndrome and the overactive bladder: the inflammatory link. Curr Urol Rep 2008; 9: 314-319
3. Keay S., Cell signaling in interstitial cystitis/painful bladder syndrome. Cell Signal 2008; 20: 2174-2179
4. Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, Chancellor MB,. Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology 2004; 64: 871-875
5. Lucioni A, Bales GT, Lotan TL, McGehee DS, Cook SP, Rapp DE,. Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute and chronic inflammation. BJU Int 2008; 101: 366-370
6. Liu HT, Kuo HC,. Intravesical botulinum toxin A injections plus hydrodistention can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology 2007; 70: 463-468
7. Giannantoni A, Costantini E, Di Stasi SM, Tascini MC, Bini V, Porena M,. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot stud. Eur Urol 2006; 49: 704-709
8. Giannantoni A, Porena M, Costantini E, Zucchi A, Mearini L, Mearini E,. Botulinun A toxin intravesical injection in atents with painful bladder syndrome: 1-year followup. J Urol 2008; 179: 1031-1034
9. Kuo HC, Chancellor MB,. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. BJU Int 2009; 104: 657-661
10. O'Leary MP, Sant GR, Fowler FJ, Jr, Whitmore KE, Spolarich-Kroll J,. The interstitial cystitis symptom index and problem index. Urology 1997; 49: 58-63
11. Homma Y, Ueda T, Tomoe H, et al. Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome. Int J Urol 2009; 16: 597-615
12. Nickel JC, Barkin J, Forrest J, et al. Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology 2005; 65: 654-658
13. Kaczmarek E, Gorna A, Majewski P,. Techniques of image analysis for quantitative immunohistochemistry. Rocz Akad Med Bialymst 2004; 49 (Suppl 1): 155-158
14. Hurst RE, Moldwn RM, Mulholland SG,. Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis. Urology 2007; 69: 17-23
15. Hauser PJ, Dozmorov MG, Bane BL, Slobodov G, Culkin DJ, Hurst RE,. Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis. J Urol 2008; 179: 764-769
16. Kiuchi H, Tsujimura A, Takao T, Yamamoto K, Nakayama Y, et al. Increased vascular endothelial growth factor expression in patients with bladder pain syndrome/interstitial cystitis: its association with pain severity and glomerulations. BJU Int 2009; 104: 826-831
17. Graham E, Chai TC,. Dysfunction of bladder urothelium and bladder urothelial cells in interstitial cystitis. Curr Urol Rep 2006; 7: 440-446
18. Yamada T, Mishimura M, Mita H,. Increased number of apoptotic cells in bladder of interstitial cystitis patients. World J Urol 2007; 25: 407-413
19. Shie JH, Kuo HC,. Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome. BJU Int 2011; 108 (2 Pt 2): E136-141
20. Shie JH, Liu HT, Kuo HC,. Increased cell apoptosis of the urothelium is closely linked to chronic inflammation in interstitial cystitis/painful bladder syndrome. Urology 2012; 79: 484.e7-13
21. Ma Y, Zhang B, Qian R, et al. Tryptase activates PKB in inflammatory reaction in ECV304 cells. Biochim Biophys Acta 2006; 1763: 313-321
22. Tamaki M, Saito R, Ogawa O, Yoshimura N, Ueda T,. Possible mechanisms inducing glomerulatons in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factor. J Urol 2004; 172: 945-948
23. Thompson HG, Mih JD, Krasieva TB, Tromberg BJ, George SC,. Epithelial-derived TGF-beta2 modulates basal and wound-healing subepithelial matrix homeostasis. Am J Physiol Lung Cell Mol Physiol 2006; 291: L1277-1285
24. Kawasaki H, Morooka T, Shimohama S, et al. Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol Chem 1997; 272: 18518-18521
25. Ma FY, Tesch GH, Flavell RA, et al. MKK3-p38 signaling promotes apoptosis and the early inflammatory response in the obstructed mouse kidney. Am J Physiol Renal Physiol 2007; 293: F1556-1563
26. Kim J, Keay SK, Freeman MR,. Heparin-binding epidermal growth factor-like growth factor functionally antagonizes interstitial cystitis antiproliferative factor via mitogen-activated protein kinase pathway activation. BJU Int 2009; 103: 541-546